NYSE: PTN
Palatin Technologies Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their PTN stock forecasts and price targets.

Forecast return on equity

Is PTN forecast to generate an efficient return?

Company
295.01%
Industry
20.54%
Market
331.62%
PTN's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is PTN forecast to generate an efficient return on assets?

Company
13.57%
Industry
14.95%
PTN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

PTN earnings per share forecast

What is PTN's earnings per share in the next 1 years based on estimates from 3 analysts?

Avg 1 year Forecast
$0.69

PTN vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
PTN$10.80N/AN/A
HOTH$1.19$5.00+320.17%Strong Buy
ALLR$1.18$9.25+683.90%Buy
LSTA$2.12$23.50+1,008.49%Strong Buy
FBLG$0.37$10.00+2,617.39%Strong Buy

Palatin Technologies Stock Forecast FAQ

What is PTN's earnings growth forecast for 2026-2026?

(NYSE: PTN) Palatin Technologies's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 191.64%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 2,926.85%.

Palatin Technologies's earnings in 2025 is -$4,806,166.

In 2026, PTN is forecast to generate $1,169,397 in earnings, with the lowest earnings forecast at -$867,683 and the highest earnings forecast at $3,361,080.

If you're new to stock investing, here's how to buy Palatin Technologies stock.

What is PTN's forecast return on equity (ROE) for 2026-2026?

(NYSE: PTN) forecast ROE is 295.01%, which is considered strong.

What is PTN's Earnings Per Share (EPS) forecast for 2026-2026?

(NYSE: PTN) Palatin Technologies's current Earnings Per Share (EPS) is -$8.34. In 2026, PTN's EPS is forecast to hit $0.69 (min: -$0.51, max: $1.97).

What is PTN's forecast return on assets (ROA) for 2026-2026?

(NYSE: PTN) forecast ROA is 13.57%, which is lower than the forecast US Biotechnology industry average of 14.95%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.